| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.09 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.08 | 0.09 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |